• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过大规模筛查发现的肺癌患者与有症状就诊的肺癌患者的结局。

Outcome of patients with lung cancer detected by mass screening versus presentation with symptoms.

作者信息

Satoh H, Ishikawa H, Yamashita Y T, Naito T, Takahashi H, Kamma H, Saito Y, Ohtsuka M, Hasegawa S

机构信息

Department of Respiratory Medicine, University of Tsukuba, Japan.

出版信息

Anticancer Res. 1997 May-Jun;17(3C):2293-6.

PMID:9216704
Abstract

Lung cancers in the early stages are frequently detected via mass screening in Japan. The aim of this study is to evaluate the outcome of patients with lung cancer detected via mass screening and to compare them to those in whom the malignancy was detected by symptoms. A total of 774 untreated patients with lung cancer who were admitted to Department of Respiratory Medicine, Tsukuba University Hospital over a 20 year period up to 1995, were analyzed with reference to their reasons for detection of the cancer. In the mass screened group(116 patients), 50.0% of lung cancer was detected at stage I of TNM classification, while only 8.2% of patients with symptoms(561 patients) had stage I lung cancer (p = 0.0001). As lung cancers detected via mass screening were more often at operable stage (stage I, II or IIIA) (p = 0.0001), surgical treatment was chosen more frequently in the mass screened group(p = 0.0001). The outcome of patients with lung cancer detected via mass screening was more favorable than that of the patients detected by their symptoms (p = 0.0002). The early detection of lung cancer via mass screening contributes to improvement of the outcome.

摘要

在日本,早期肺癌常通过大规模筛查被发现。本研究旨在评估通过大规模筛查发现的肺癌患者的治疗结果,并将其与因出现症状而被发现患有恶性肿瘤的患者进行比较。对截至1995年的20年间入住筑波大学医院呼吸内科的774例未经治疗的肺癌患者,根据其癌症发现原因进行了分析。在大规模筛查组(116例患者)中,50.0%的肺癌在TNM分期的I期被发现,而有症状的患者(561例患者)中只有8.2%患有I期肺癌(p = 0.0001)。由于通过大规模筛查发现的肺癌更常处于可手术阶段(I期、II期或IIIA期)(p = 0.0001),因此大规模筛查组更常选择手术治疗(p = 0.0001)。通过大规模筛查发现的肺癌患者的治疗结果比因症状发现的患者更有利(p = 0.0002)。通过大规模筛查早期发现肺癌有助于改善治疗结果。

相似文献

1
Outcome of patients with lung cancer detected by mass screening versus presentation with symptoms.通过大规模筛查发现的肺癌患者与有症状就诊的肺癌患者的结局。
Anticancer Res. 1997 May-Jun;17(3C):2293-6.
2
Outcome of patients with lung cancer detected incidentally.偶然发现的肺癌患者的预后。
Oncol Rep. 2004 Oct;12(4):945-8.
3
Time from finding abnormality on mass-screening to final diagnosis of lung cancer.从大规模筛查发现异常到肺癌最终确诊的时间。
Oncol Rep. 2003 May-Jun;10(3):649-52.
4
Current status of screening for lung cancer.肺癌筛查的现状
Chest Surg Clin N Am. 1994 Feb;4(1):1-15.
5
Surgical treatment of primary lung cancer with synchronous brain metastases.原发性肺癌伴同步脑转移的外科治疗
J Thorac Cardiovasc Surg. 2001 Sep;122(3):548-53. doi: 10.1067/mtc.2001.116201.
6
The surgical treatment of lung cancer: a retrospective analysis of 2004 cases.肺癌的外科治疗:2004例病例的回顾性分析
Chin Med J (Engl). 1999 Jan;112(1):25-8.
7
The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.血清铁蛋白浓度是原发性肺癌患者生存的重要预后指标。
Oncol Rep. 2002 Jan-Feb;9(1):193-8.
8
[Comparison of screening-detected and symptomatic lung cancer patients].[筛查发现的肺癌患者与有症状的肺癌患者的比较]
Gan To Kagaku Ryoho. 1998 Aug;25(10):1486-92.
9
Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.一项基于人群的1996 - 1998年使用移动低剂量螺旋计算机断层扫描进行肺癌大规模筛查项目的长期随访研究。
Lung Cancer. 2007 Dec;58(3):329-41. doi: 10.1016/j.lungcan.2007.06.022. Epub 2007 Aug 6.
10
Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.肺癌患者在I期试验中的生存及预后因素:日本经验
Int J Oncol. 1999 Oct;15(4):737-41.

引用本文的文献

1
Use of screening tests, diagnosis wait times, and wait-related satisfaction in breast and prostate cancer.筛查试验的使用、诊断等待时间和乳腺癌与前列腺癌的等待相关满意度。
Curr Oncol. 2014 Jun;21(3):e441-8. doi: 10.3747/co.21.1843.
2
Volume doubling time of lung cancers detected in a chest radiograph mass screening program: Comparison with CT screening.在胸部X光片大规模筛查项目中检测到的肺癌体积倍增时间:与CT筛查的比较。
Oncol Lett. 2012 Sep;4(3):513-516. doi: 10.3892/ol.2012.780. Epub 2012 Jun 28.